Skip to main content
Premium Trial:

Request an Annual Quote

Danish Team Hopes to Use Genomic, Proteomic Tools to Make Food Tastier (Really)

NEW YORK, Nov. 12 (GenomeWeb News) - Four Danish firms have presented a plan to their government to apply genomics and proteomics techniques to give a better understanding of the interactions between food molecules and humans, which may lead to the design of safer and better-tasting foods.


Per Falholt, a member of the steering committee behind the strategy and an official with Novozyme, said he hopes that plan can get at least 5 million Danish krone ($869,813) in funding for the next five years.


"The ability to produce the food products which consumers are expected to demand in the future is dependent on more fundamental knowledge about the significant factors for eating quality of food," reads part of a written description of the 10-year plan.


The plan was presented to the Danish parliament by the firms Danisco, Arla Foods, Cr Hansen, and Novozymes. It calls for academic units to work in close collaboration with industry.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.